A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

NCT05621317 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Peanut Allergy
Peanut Hypersensitivity
Peanut-Induced Anaphylaxis
Immune System Diseases

Interventions

BIOLOGICAL: PVX-108
BIOLOGICAL: Placebo

Sponsor

Aravax Pty Ltd